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Abstract
Background: Phospholamban (PLN) is an effective inhibitor of the sarco(endo)plasmic reticulum Ca
2+-ATPase, which
transports Ca
2+ into the SR lumen, leading to muscle relaxation. A mutation of PLN in which one of the di-arginine residues
at positions 13 and 14 was deleted led to a severe, early onset dilated cardiomyopathy. Here we were interested in
determining the cellular mechanisms involved in this disease-causing mutation.
Methodology/Principal Finding: Mutations deleting codons for either or both Arg13 or Arg14 resulted in the mislocalization of
PLN from the ER. Our data show that PLN is recycled via the retrograde Golgi to ER membrane traffic pathway involving COP-I
vesicles, since co-immunoprecipitation assays determined that COP I interactions are dependent on an intact di-arginine motif as
PLN RD14 did not co-precipitate with COP I containing vesicles. Bioinformatic analysis determined that the di-arginine motif is
present inthefirst25 residues in alargenumberof all ER/SR GeneOntology (GO) annotated proteins.Mutations in the di-arginine
motif of the Sigma 1-type opioid receptor, the b-subunit of the signal recognition particle receptor, and Sterol-O-acyltransferase,
three proteins identified in our bioinformatic screen also caused mislocalization of these known ER-resident proteins.
Conclusion: We conclude that PLN is enriched in the ER due to COP I-mediated transport that is dependent on its intact di-
arginine motif and that the N-terminal di-arginine motif may act as a general ER retrieval sequence.
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Introduction
Sarco(endo)plasmic reticulum Ca
2+-ATPases (SERCAs) are
110-kDa membrane proteins that transport Ca
2+ from the cytosol
actively to the lumen of the sarco(endo)plasmic reticulum. In
cardiac muscle, SERCA2a can associate with a 52-amino acid
transmembrane phosphoprotein, phospholamban (PLN) [1]. In its
dephosphorylated form, PLN interacts with SERCA2a to inhibit
Ca
2+ transport by lowering the apparent affinity of SERCA2a for
Ca
2+: upon PKA-mediated phosphorylation of PLN, its inhibitory
effect on SERCA2a is relieved [2]. The ability of PLN to regulate
SERCA2a activity, thereby regulating the rate of cardiac
relaxation and the size of the SR Ca
2+ store, makes PLN a
crucial regulator of cardiac function [3]. Recently, a mutation of
PLN in which one of the N-terminal di-arginine residues at
positions 13 and 14 was deleted led to a severe, early onset dilated
cardiomyopathy [4]. In fast twitch skeletal muscle SERCA1a
associates with sarcolipin (SLN), a 31-amino acid protein which is
an effective inhibitor of the SERCA molecule [5–7]. PLN and
SLN share significant amino acid sequence identity and gene
structure and are clearly homologous members of a gene family
[5,8]. We have previously reported that the RSYQY amino acid
sequence at the C-terminus of SLN is vital in the retention of SLN
in the ER/SR membrane [9]. The deletion of this sequence results
in the mislocalization of SLN. However, the lack of this sequence
in PLN implied that the retention of PLN in the ER/SR
membrane is conducted by a different mechanism.
Two distinct mechanisms for maintaining and concentrating
proteins in the ER have been well defined: (1) ER proteins could
be retained by active exclusion from vesicles that exit the ER, or
(2) ER proteins exit the ER, but are subsequently retrieved from a
post-ER compartment via a retrograde transport flow [10].
Concerning ER retrieval, the well characterized KDEL motif in
the C-terminal region of soluble ER proteins, together with the
KDEL receptor protein, Erd2p, has been shown to mediate the
retrieval of luminal ER proteins from the Golgi apparatus [11]. In
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been shown to have an ER retention signal consisting of a di-lysine
motif, KKxx or xKxK, located near the C terminus. In these
cases, lysine must be positioned three residues from the C-terminus
and the second residue must be present either four or five residues
from the C-terminus [12]. These lysines have been shown to form
part of an interaction site with coatomer protein I (COP-I)
[10,13,14]. The role and mechanism of the N-terminal di-arginine
motif xRRx, in ER retention is less established. However, the di-
arginine motif has been demonstrated to be essential for correct
expression of the plasma membrane K
+ (ATP)-sensitive potassium
channel. Functional K
+-ATP channels exists as octamers, but the
subunits are expressed and retained in the ER by a C-terminal di-
arginine motif. Only after the assembly of the complete octamer
and the masking of the di-arginine motif is the K
+-ATPase
transported to the plasma membrane [15,16].
In the present study, we describe evidence showing that the di-
arginine motif, located near the N-terminus of PLN at positions 13
and 14, may be responsible for ER enrichment of PLN. A greater
understanding of the role of this domain in regulating PLN in
cardiac muscle appears further warranted, given our recent finding
that a deletion in the human PLN gene, deleting arginine 14
(RD14) results in lethal hereditary cardiomyopathy [4]. We
performed site-directed mutagenesis to generate arginine motif
mutants and analyzed the subcellular localisation of PLN and
these mutants. Here we report that mutation or deletion of either
arginine in the di-arginine motif results in mislocalization of PLN
from the ER.
Results
Mutation in di-arginine motif causes mislocalization of
PLN.
PLN and SLN share significant amino acid sequence homology
(Figure 1A and B). We have previously shown that the RSYQY
amino acid sequence at the C-terminus of SLN is vital in the
retention of SLN in the ER/SR membrane [9]. The lack of a
known ER retention sequence in PLN and the finding that the
deletion of arginine 14 causes lethal human cardiomyopathy led us
to create a PLN RD14 construct as well as a series of constructs
that contain mutations in one or both arginine residues
(Figure 1C). Subcellular fractionation by sucrose density
gradients is a well established technique for separating different
organelles [17,18]. We used a continuous sucrose gradient to
examine PLN trafficking upon mutation of the di-arginine motif.
HEK cells were transiently transfected with plasmids expressing
either an intact di-arginine motif (WT) or one of three constructs
containing a mutated di-arginine motif (PLN RD14, PLN R13E or
PLN R13E/R14E) (see Fig. 1). Lysates were separated on a 20–
60% sucrose gradient (as described in materials and methods) and
13 equal volume fractions were collected and analysed by
immunoblotting (Figure 2). Wildtype PLN, with an intact di-
arginine motif, eluted in fractions 1–7. SERCA2a, the major
protein of the sarcoplasmic reticulum and the protein most likely
to interact with wt PLN [19,20], was also found in fractions 1–7.
Coatomer protein I (COP-I), a protein involved in the retrieval of
membrane proteins to the ER was found in lanes 1–8. We
analysed two other known resident ER proteins, calnexin [21]
which showed staining in lanes 1–8, and protein disulfide
isomerase (PDI) [22] showed staining in lanes 1–6, thereby
demonstrating that ER proteins are eluted in the heavier fractions
of the sucrose density gradient. The estrogen receptor beta, a
known nuclear membrane protein [23] eluted in lanes 1–4. The
elution profiles of the PLN di-arginine mutants, however, differed
considerably from wildtype PLN. PLN R13E showed some elution
in fractions 1–6 but more than 50% of PLN R13E eluted in
fractions 7–10. The double PLN mutant (PLN R13E/14E) only
eluted in fractions 7–12. The profile of PLN RD14 was less
uniform than wildtype PLN with small amounts eluted in fraction
3, while the bulk of the mutant eluted in fractions 6–10 indicating
a significant shift towards lighter fractions. In fact, more than 15%
of mutant PLN eluted in fractions 10–13, where the Na/Ca
exchanger and the Na/K ATPase, two known plasma membrane
proteins [24], were also seen to elute. The elution profiles of both
PLN R13E and PLN R13E/14E showed overlap with the trans
golgi protein 2 (TGOLN2; also known as TGN46) which eluted in
fractions 7–12. TGN46 is a marker of trans golgi network [25] and
its elution profile overlaps in part with the profiles of the plasma
membrane markers Na/Ca exchanger and the Na/K ATPase.
To visualize the subcellular localization of wildtype and mutant
PLN constructs, we performed confocal microscopy examining
transiently transfected cells HEK-293 cells and larger, primary
fibroblasts. In HEK-293 cells (Figure 3A) wildtype NF-PLN
Figure 1. Schematic representation of SLN, PLN and PLN
expression constructs. Model of rabbit (A) SLN and (B) PLN amino
acid sequence. Note PLN has di-arginine residues in its N-terminal but a
lack of C-terminal luminal domain as seen in SLN. (C) PLN expression
constructs were generated with an N-terminal FLAG epitope. NF-PLN
point and deletion mutants were generated subsequently by site
directed mutagenesis.
doi:10.1371/journal.pone.0011496.g001
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organized web-like distribution throughout the cell (Figure 3A);
presented a well defined and typical staining pattern of ER
targeted proteins, as demonstrated previously [9]. Similarly, well
defined ER staining patterns were also seen in the primary
fibroblasts (Figure 3B) as exemplified by the staining of the
known ER resident proteins calreticulin [26] and ERGIC-53 [27]
in primary fibroblasts (Figure 3B). However, the PLN constructs
containing mutations in the di-arginine motif show disrupted ER
staining patterns in both HEK cells and fibroblasts (Fig. 3A and
3B). Specifically, the R13E and R13A mutants have a more
punctate staining pattern with large aggregates found close to the
nuclear region, along with some evidence of plasma membrane
staining, which was never observed in wildtype PLN-transfected
cells (Figure 3A). This was also true for the double mutant R13E/
R14E and the PLN RD14 construct which showed the same
punctate staining with a significant amount of expression found in
the plasma membrane (Figure 3A). Similar diffuse cytosolic
staining and pronounced plasma membrane staining patterns were
observed in the SLN mutants with disrupted ER sorting sequences
[9]. Since the focus of this study was the PLN RD14 mutation that
causes human cardiomyopathy, we carried out further staining for
this construct in larger, more defined primary fibroblasts
(Figure 3B). Here, we saw clear plasma membrane staining of
the PLN RD14 which was comparable to the membrane staining
of the two known plasma membrane proteins, namely the Na/K
ATPase and the Na/Ca Exchanger.
In order to gain direct evidence that a mutated di-arginine motif
causes mislocalization to the plasma membrane, we co-transfected
primary fibroblasts with either wildtype NF-PLN and a RGS2-
GFP (D1-71 amino acid) construct previously shown to be plasma
membrane localised protein [28] (and a kind gift from Dr. Scott
Heximer,U of Toronto) or PLN RD14 with RGS2-GFP. Co-
staining of RGS2-GFP with wildtype PLN showed a distinct
staining pattern for both proteins with RGS2-GFP localising to the
plasma membrane and wildtype PLN to the ER (Figure 4) with no
overlap between the two proteins. However, in contrast, PLN
RD14 showed significant overlap with RGS2-GFP in the plasma
membrane, providing further evidence of the mislocalization of
PLN containing a mutated di-arginine motif (Figure 4).
Detection of cellular proteins associating with PLN.
In order to identify PLN interacting proteins, HEK cells were
radiolabeled with
35S-methionine (Easytag express protein labelling
mix, Perkin Elmer) for 2 hours, washed for 4 hours, and lysates
collected 48 hours later. Radiolabeled lysates from NF-PLN
transfected cells were subjected to immunoprecipitations using the
anti-Flag antibody M2 and then subjected to SDS-PAGE and
exposed onto autoradiographs (Figure 5A). Protein bands unique
to NF-PLN and, therefore, representing potential binding partners
of PLN, were seen at ,130, 80, 68, 62, 50, 45 and 18 kDa. SERCA
and PLN bands were evident at 110 kDa and ,10 kDa,
respectively. Control experiments were carried out with lysates
from NF-SLN transfected cells and lysates from un-transfected cells
that were processed in parallel. NF-PLN showed unique bands
when compared to NF-SLN which can then be implicated as
exclusive binding partners of PLN. Untransfected cells failed to
show any specific enriched bands when subjected to SDS-PAGE.
Similarly, to identify proteins associating with endogenous PLN
we carried out a second series of immunoprecipitations using the
anti-PLN antibody 1D11 and fresh cardiac total muscle lysates.
Protein bands were seen in a coomassie stained gel (Figure 5B)a t
molecular weights similar to those observed in the transfected
HEK cells although not all the bands seen in the HEK cells were
observed with the cardiac lysates, possibly due to differences in the
immunoprecipitations carried out with HEK cells and cardiac
lysates and the difference between the anti-Flag antibody M2 and
the anti-PLN antibody 1D11.
Identification of cellular proteins associating with PLN.
The recent findings that di-arginine motif binds to COP I [29]
and that the position of the di-arginine motif is flexible throughout
the protein [10,30], led us to the hypothesis that PLN was involved
in di-arginine mediated transport and prompted us to investigate
the involvement of coatomer protein I (COP I) in PLN trafficking.
PLN transfected HEK cells were analysed for co-localisation by
immunofluorescence between PLN and COP I. When probed
with PLN antibody 1D11 and COP I antibody (Figure 6A), the
cells showed clear ER staining of both proteins and significant
overlap of fluorescence, indicative of co-expression and general co-
localization of these two proteins, as would be anticipated given
the known localization of these proteins.
To verify binding of PLN and COP-I proteins, we performed
co-immunoprecipitations by precipitating endogenous PLN from
heart tissue with anti-PLN 1D11 and examining binding partners
Figure 2. PLN arginine mutants are not retained in the ER.
Subcellular fractionation of wild type NF-PLN, and di-arginine motif PLN
mutants; RD14 PLN, R13E and R13E/14E. HEK cells were transiently
transfected with tagged WT-PLN or PLN mutants and cell lysates run on
a continuous 20–60% sucrose gradient. Fractions 1–13 contain the
highest to lowest sucrose concentrations respectively. ER markers
SERCA2a, coatomer protein I (COP-I), protein disulfide isomerase (PDI)
and calnexin as well as plasma membrane protein markers Na/K ATPase
and Na/Ca exchanger (NCX), a nuclear protein, estrogen receptor beta,
and a trans golgi network marker (TGN46) were detected as markers to
monitor the fractionation procedure. A minimum of 3 experiments were
performed for each gradient.
doi:10.1371/journal.pone.0011496.g002
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and known PLN binding partner SERCA2a and showed clear co-
immunoprecipitation between these two interacting proteins
(Figure 6B). Next, we determined that COP I binds with PLN,
with a clear band observed in a COP-I immunoblot, at
approximately 130 kDa (Figure 6C). Additional western blot
analyses of the immunoprecipitated sample also identified two
other proteins (ARFGAP1 and ARF1) that are known to be
involved in COP I mediated transport [31–33]. Distinct bands
were observed in these blots at the appropriate molecular weights:
ARFGAP1 at ,45 kDa; and ARF1 at ,18 kDa (Figure 6C).
Di-Arginine dependent COP I binding of PLN.
To investigate the involvement of the di-arginine motif in COP
I modulated transport cell lysates from cultures transfected with
either NF-PLN, NF-PLN RD14 or NF-R13E/R14E were
subjected to immunoprecipitations with anti-Flag antibody
(Figure 6D). COP I co-immunoprecipitated with NF-PLN,
which was detected by a western blot using COP I antibody.
However, COP I showed a marked five-fold reduction in band
intensity when co-immunoprecipitated with either NF-PLN RD14
or NF-R13E/R14E. This shows that PLN binding to COP I is
dependent on the intact di-arginine motif.
Figure 3. PLN arginine mutants are mislocalized out of the ER. (A) HEK cells were transiently transfected with tagged WT-PLN or PLN mutants
and visualized by confocal microscopy to detect the flag tag. Note that mutation of either Arg13 or Arg14, or both together, resulted in
mislocalization of PLN out of the ER with significant expression at the plasma membrane. Cells shown represent at least 20 representative cells per
condition. (B) Primary mouse fibroblasts were transiently transfected with tagged WT-PLN or the RD14 PLN construct and visualized by confocal
microscopy. Endogenous ER markers ERGIC-53 and calreticulin as well as plasma membrane protein markers Na/K ATPase and Na/Ca exchanger (NCX)
were probed against to allow accurate visualization of the ER and the plasma membrane. WT-PLN shows staining similar to the ER markers and RD14
PLN shows more diffuse ER staining as well as pronounced plasma membrane staining. Inserts shows a higher magnification of the cell membrane.
Note, no plasma membrane staining is seen in WT-PLN and the other ER proteins but clear membrane staining is seen for RD14 PLN and the plasma
membrane proteins NCX and Na/K ATPase. (Scale bar, 10 mm)
doi:10.1371/journal.pone.0011496.g003
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To verify that PLN was binding directly to COP, we cloned
COP, PLN and PLN RD14 into a His-tagged bacterial expression
vector (pET28-MHL Vector; GenBank accession #EF456735), a
kind gift from Dr Sirano Dhe-Paganon (U of Toronto). Proteins
were purified individually using cobalt beads (see methods) and
purified COP was incubated with either purified wild type PLN or
purified PLN RD14 (Figure 6E). In vitro co-immunoprecipitation
assays were performed with the COP antibody. Immunoblots
using the anti-His antibody showed that wild type PLN was
present in the COP-precipitated eluate however, PLN RD14 was
not co-immunoprecipitated. These experiments provide evidence
of direct binding between PLN and COP and provides further
evidence that PLN binding to COP I is dependent on its intact di-
arginine motif.
Bioinformatic analysis of ER/SR proteins
Altogether, these findings then led us to investigate the potential
that the di-arginine motif may be a common ER/SR retention
motif that directs protein enrichment in the ER. From the human
IPI protein sequence database we extracted all of the human ER
(GO: 0005783) and human SR (GO: 0016529) annotated
proteins, which represents all proteins that have a known and
annotated ER and SR localization (Figure 7A). We then analyzed
this list to identify proteins that contain: the motif RR within the
proteins first 25 residues; the KK within the proteins last 25
residues; and proteins with the sequence XDEL at the C-terminus
(Table S1). In total we found: 152 proteins containing the RR
motif of which 84 had one or more transmembrane domains; 191
proteins containing the KK motif, of which 109 had one or more
transmembrane domain and 34 proteins containing the XDEL
motif, of which 24 were annotated to be found in the ER/SR
lumen (Figure 7B). The enrichment in the RR and KK motifs in
proteins with greater than one transmembrane domain when
compared to the XDEL motif, which is enriched in proteins with
no membrane domains, is as expected, since the XDEL motif
mediates the retrieval of luminal ER proteins from the Golgi
apparatus lumen proteins. Further annotation of these proteins
into membrane protein types showed that the majority of proteins
containing the KK and RR motifs were type 3 multi-membrane
pass proteins (Figure 7B). Next, to characterize the Cellular
Component ontology of the proteins identified in our bioinformatic
screen containing the RR and XDEL motif we used the Gene
Ontology schema and calculated significantly enriched GO-terms
(Table 1). We found cellular component enrichments for the RR
Figure 4. PLN arginine mutants co-localise with a known plasma membrane protein. Primary mouse fibroblasts were transiently co-
transfected with a known plasma membrane localised RGS2-GFP construct (D1-71 amino acids) and either flag-tagged WT-PLN or the RD14 PLN
construct, and visualized by confocal microscopy. WT-PLN did not show any plasma membrane staining and did not co-localise with the RGS2- GFP.
However, RD14 PLN showed clear plasma membrane staining which was then confirmed with it co-localising with RGS2-GFP. (Scale bar, 10 mm)
doi:10.1371/journal.pone.0011496.g004
Figure 5. Identification of PLN interacting proteins. (A) HEK cells
were transiently transfected with either tagged WT-PLN or tagged WT-
SLN and then incubated with
35S-methionine for 6 hours. Untransfected
cells were used as a control. IPs were performed with anti-flag antibody,
prominent bands found in the PLN sample. (B) Coomassie stained SDS-
PAGE gel of co-immunoprecipitated endogenous PLN from cardiac
tissue. Lines indicate prominent proteins in sample, note molecular
weights are similar to protein bands found in A.
doi:10.1371/journal.pone.0011496.g005
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PLoS ONE | www.plosone.org 5 July 2010 | Volume 5 | Issue 7 | e11496Figure 6. PLN binds to COP I coated transport vesicles in a di-arginine dependent manner. (A) Transfected HEK cells analyzed by confocal
immunofluorescence experiments to detect PLN using anti-PLN antibody 1D11 and Fluor488, and the retrograde transport vesicle coat protein COP I
detected using COPI antibody and Fluor633. (B) Co-immunoprecipitation of endogenous PLN from mouse heart tissue using anti-PLN antibody 1D11
RR Motif and PLN Targeting
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vesicles,’ both of which are components associated with vesicular
protein trafficking. In contrast, the XDEL motif showed
enrichments in ‘endoplasmic reticulum lumen’,‘ membrane enclosed lumen’
and ‘organelle lumen’, which are all components associated with
soluble, lumenal proteins. The KK cluster did not contain any
significant GO term enrichments.
Conservation of amino acid sequences across species infers that
these sequences are either essential for viability and/or essential
for interaction with other proteins [34]. We then used the Basic
Local Alignment Search Tool (BLAST) to determine if the di-
arginine motif identified in the bioinformatic screen in the first 25
residues were conserved throughout multiple species within the
proteins containing one or more transmembrane domains. We
found that the motif overall is preserved in 68% of mouse
orthologues, 75% of bovine orthologues and 93% of chimpanzee
orthologues (Figure 8A and Table S2). Comparable conserva-
tion was seen between protein orthologues containing one or more
transmembrane domains with the known di-lysine motif in the last
25 residues and elevated conservation of the XDEL motif was seen
in luminal proteins (Figure 8A and 8B). These findings further
point to the importance of the di-arginine motif, given its
conservation across multiple species.
The di-arginine motif -a general ER retention motif?
In order to determine whether the di-arginine motif regulates a
diverse set of proteins in the cell, we randomly selected two further
membrane proteins identified in the bioinformatic screen as
containing a di-arginine motif in the first 25 residues, and which
had an available full length cDNA, and carried out site-directed
mutagenesis of the di-arginine motif to glutamic acid.
The Sigma 1-type opioid receptor (Sigma 1R) is a broadly
distributed integral membrane protein known to modulate various
voltage-gated K
+ and Ca
2+ channels [35,36]. Subcellular locali-
zation analysis by sucrose density fractionation of wild type sigma
1-type opioid receptor shows a tight localisation in heavy fractions
1–6, which is comparable to the ER markers seen in Figure 2.
Mutation of both of the arginines in the di-arginine sequence
(R7E/R8E) in Sigma 1R lead to a disrupted protein fractionation
pattern with a significant amount of protein found in the lighter
fractions, although protein was found across all fractions 1–12
(Figure 9A). Co-immunoprecipitation assays in HEK cells
showed that COP I precipitated wild type Sigma 1R with a
greater than two-fold band intensity than with the di-arginine
mutated Sigma 1R (Figure 9B).
The b-subunit of the signal recognition particle receptor (SR b),
is an ER membrane-embedded subunit of the signal recognition
complex that is involved in the release of nascent polypeptide
chains to the protein translocation machinery in the endoplasmic
reticulum membrane [37,38]. In Figure 9C, we show by sucrose
density fractionation of WT SR b and an SR b di-arginine mutant
(R7E/R8E). Wild type SR b localized in the heavy fractions 3–8,
like the ER markers shown in Fig. 2, whereas the SR b di-arginine
mutant localized predominantly in the light fractions 8–12
(Figure 9C) similar to the plasma membrane markers shown in
Fig. 2. Co-immunoprecipitation assays also showed that COP I
precipitated wild type SR b with a greater than two-fold intensity
than the di-arginine mutated SR b (Figure 9D).
As a final candidate to test, we examined sterol-O-transferase
(SOAT) which contains a xRxR motif within its first 25 amino acid
residues. SOAT is an intracellular enzyme in the endoplasmic
reticulum that covalently joins cholesterol and fatty acyl-CoA
molecules to form cholesterol esters. It is a key enzyme in cellular
cholesterol homeostasis [7]. Due to restricted cloning sites, SOAT
cDNA (obtained from OriGene) was cloned into the Interplay
Mammalian TAP vector, pCTAP (Stratagene) which contains a
dual streptavidin binding peptide tag and a calmodulin binding
peptide tag. Mutation of both arginine residues (R10E/R12E) in
the motif resulted in the mislocalization of SOAT from the ER as
monitored by sucrose density fractionation. Wild type SOAT
localized in the heavy fractions 1–7, whereas the SOAT di-
arginine mutant dispersed throughout the gradient (Figure 9E).
Tandem affinity purification of wild type SOAT and di-arginine
mutated SOAT was then carried out (see methods) and probed for
COP I binding. Wild type SOAT purified with COP I but the di-
arginine mutant purified SOAT did not copurify with COP I
(Figure 9F).
Discussion
PLN is recycled via COP I mediated retrograde transport
Previously, we have shown that the RSYQY amino acid
sequence at the C-terminus of SLN is vital in its ER/SR
localisation [9]. The lack of this luminal sequence in PLN led us
to pursue other mechanisms for PLN targeting to the ER/SR. In
this study, we have shown that PLN retention in the ER is
dependent on its R13/R14 di-arginine motif. The di-arginine
motif had previously been implicated as an ER trafficking and
retention signal. For instance, the correct assembly of multimeric
plasma membrane proteins such as the K
+(ATP)-sensitive channel
and the GABAB receptor is tightly coupled to the retention of their
individual subunits within the ER [15,39]. The K
+(ATP) channel
exists as an octameric complex composed of four pore-forming a
subunits (Kir6.1/2), which have a RKR motif at the C-terminus
and four sulphonylurea-binding b subunits (SUR1/2A/2B) with a
RKR motif in the cytoplasmic loop. When correctly folded in its
octameric form, the RKR motif in both subunits is masked and
only then is the K
+(ATP) channel exported to the cell surface.
However, systematic removal of the RKR motif from the C-
terminus of Kir6.2 resulted in significant expression at the cell
surface [15,39]. In the GABAB receptor, the GB1 subunit contains
a C-terminal RXR(R) motif and the surface expression of the
functional receptor requires heterodimerization of GB1 and GB2
subunits [15,39]. The retention signal is shielded by the
interactions between GB1 and GB2 through the coiled-coil
domains, thereby allowing the assembled GABAB to traffic to
followed by western blot anlaysis using 1D11 (left panel) or anti-SERCA2 antibody (right panel). IgG beads alone were used as negative controls. (C)
Co-immunoprecipitation of PLN in wildtype mouse hearts was also analyzed for COP I (left panel), ARFGAP 1 (middle panel) and ARF (right panel); the
essential core proteins in coatomer coated vesicles. IgG beads alone were used as negative controls. Lower panels are immunoblots showing equal
loading of cardiac lysate to each reaction. (D) Co-immunoprecipitation performed using cell lysates from NF-PLN and NF-RD14 and NF-R13E/R14E
transfected HEK cells. NF-PLN, NF-PLN RD14 and NF-R13E/R14E mutant were precipitated using anti-flag antibody and samples were then
immunoblotted with COPI (upper panel) or anti-flag antibody (lower panel). The lower intensity signal of the RD14/COP I complex and R13E/R14E/
COP I complex shows that binding of COP I is dependent on an intact di-arginine motif. (E) In-vitro binding assays were performed using purified
proteins from cobalt beads (see methods). Purified His-COP I was combined with purified His-PLN or His-RD14. Immunoprecipitations were
performed using COP I antibody. Immunoblots with anti-His antibody were used to identify His-PLN or His-RD14 at ,5 kDa. Lower panel represent
loading controls of COP which were identified using COP antibody at ,130 kDa.
doi:10.1371/journal.pone.0011496.g006
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PLoS ONE | www.plosone.org 7 July 2010 | Volume 5 | Issue 7 | e11496Figure 7. Heat map showing classification of membrane protein types. (A) Scheme of bioinformatic work flow (B) Proteins clusters obtained
from human gene ontology sets ER (GO: 0005783) and SR (GO: 0016529) were characterized according to whether they were present in either the ER
lumen or whether they contained a transmembrane (TM) domain based on annotations found in the ExPASy database (www.expasy.org). Proteins
found to possess a TM domain were further classified according to the type of membrane protein; type 1 is a single pass protein with extracellular or
luminal N-terminus; type 2 is a single pass protein with an extracellular or luminal C-terminus; type 3 is a multipass transmembrane protein; type 4 is a
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and versatility of the di-arginine motif in ER retention and provide
a short amino acid sequence that is unrestricted by its positioning
to the very C-terminal end of a protein, as is necessary with the di-
lysine motif [10].
PLN expression has been observed outside of the ER, suggesting
that it is not exclusively contained within the ER and indicating a
requirement for further cellular trafficking mechanisms [40]. In
this study, we have established a possible mechanism for the
trafficking of PLN. Retrograde transport from the golgi to the
endoplasmic reticulum has been well studied and is clearly
mediated by COP I coated vesicles [10,31,41]. The minimal
machinery necessary to form these retrograde transport vesicles
has been shown to be only two proteins; coatomer protein and
ARF1 with bound GTP [31]. Our co-immunoprecipitation of
endogenous PLN from cardiac tissue showed that both of these
proteins are bound to PLN. We also identified ARFGAP1, a
GTPase-activating protein acting on ARF1 that has been shown to
promote vesicle formation by functioning as a component of the
COP I coat [32]. Our confocal microscopy showing complete
overlap between COPI and PLN in the ER is entirely consistent
with COPI mediated PLN trafficking. Together, our data provide
the first evidence that PLN is recycled back to the ER via COP I
mediated retrograde transport.
Correct localization of PLN requires the intact di-arginine
motif
We then investigated further the involvement of the di-arginine
motif at the N-terminus of PLN. Our recent finding of a human
deletion at Arg 14 (RD14) leading to hereditary cardiomyopathy
gave us a relevant model to investigate the di-arginine motif. We
found by confocal microscopy that mutation or deletion of either
or both Arg 13 or Arg 14 caused mislocalization of PLN from the
ER. Subcellular fractionation further enforced the finding that
wildtype PLN fractionated with SERCA2a, a known ER marker,
whereas PLN RD14, PLNR13E and the double mutant PLN
R13E/14E showed some aspects of ER staining, much of these
proteins fractioned with the Na/Ca exchanger, a known plasma
membrane protein and with TGN46 a known trans golgi network
protein. Co-immunoprecipitation further demonstrated that, in
contrast to WT PLN, PLN RD14 did not co-purify with COP I.
We confirmed direct binding between PLN and COP I by
combining cobalt bead-purified proteins and showing direct
interaction by co-immunoprecipitation of WT PLN and COP,
but a lack of interaction between PLN RD14 and COP I. These
data imply that COP I binds directly to the di-arginine motif in
PLN, since mutation of this motif results in COP I not binding to
PLN RD14 and its mislocalization to the plasma membrane.
It has been well established that PLN exists in an inhibitory
monomeric form and as a less inhibitory or inactive pentameric
form [42–45]. The normal pentamer to monomer ratio is 10:1 and
it has been determined that mutations that destabilise the
pentamer increase the active monomer concentration inhibiting
SERCA2a by altering the dissociation constant between the
monomeric and pentameric forms of PLN causing inhibition by
mass action [43,46]. Previously, it was demonstrated that PLN
RD14 mutation causes superinhibition of SERCA2a and that the
mutation causes disruption in the stability of its pentameric form
[4]. We also showed that coexpression of WT PLN together with
PLN RD14 in HEK cells led to its immunoreactivity being
localised to the ER [4]. This localization was very likely mediated
due to mutant monomers being integrated into the WT PLN
pentamer structure and maintained in the ER correctly. In this
study however, we, have expressed PLN RD14 in the complete
absence of any WT PLN, and the finding in this study that PLN
RD14 is not recovered by COP I mediated retrograde transport
and has becomes localized at the plasma membrane offers a
mechanism by which the concentration of PLN is reduced in the
ER and a possible explanation for the destabilisation of the
pentameric form of PLN.
lipid chain-anchored membrane protein; and type 5 is a GPI-anchored membrane protein. Proteins were also defined as peripheral proteins and cell
surface or extracellular surface attached proteins. Undefined proteins were those classified as having an ER/SR annotation, but no further detailed
classification was available. Red indicates the presence of annotation and black indicates the lack of annotation.
doi:10.1371/journal.pone.0011496.g007
Table 1. Gene Ontology enrichments (cellular components) of the RR and XDEL containing proteins.
Cellular Component for RR motif Count Ref. Count Raw p-value FDR p-value
nuclear membrane 18 57 1.66E-04 3.00E-02
cytoplasmic membrane-bounded vesicle 23 95 5.81E-04 3.93E-02
trans-Golgi network 9 18 6.29E-04 4.00E-02
membrane-bounded vesicle 23 98 8.46E-04 4.15E-02
cytoplasmic vesicle part 14 45 1.04E-03 4.15E-02
Cellular Component for XDEL motif
endoplasmic reticulum lumen 31 99 1.557E-25 7.927E-23
membrane-enclosed lumen 31 151 1.106E-20 1.877E-18
organelle lumen 31 151 1.106E-20 1.877E-18
ER-Golgi intermediate compartment 8 42 0.00004703 0.001596
melanosome 6 24 0.0001293 0.003234
Cellular component enrichment of the RR and XDEL motif. GO-term cellular component analysis was carried out using ProteinCenter software suite (Proxeon, Denmark)
on proteins identified in the bioinformatic screen as containing the di-arginine motif in the first 25 residues. The analysis shows significant enrichment of the di-arginine
motif in cytoplasmic membrane and membrane bound vesicles in comparison to XDEL. This is enriched in ER and organelle lumens when compared to the reference
count of total proteins found in the GO database with identifications of ER and SR. No GO-term enrichment was observed for the KK cluster.
doi:10.1371/journal.pone.0011496.t001
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retention motif
The involvement of the di-arginine motif in PLN then led us to
investigate the occurrence of the di-arginine motif in all ER and
SR gene ontology (GO) annotated proteins. The finding that the
frequency of the di-arginine motif is equivalent to the previously
well established di-lysine motif and that the di-arginine motif
proteins are localized in membrane-bounded vesicle and cytoplas-
mic membrane-bounded vesicle further supports the idea that the
di-arginine motif is a major ER retrieval signal.
Protein sequences found in different species are orthologous if
their amino acid sequences remain similar to each other
(homologous) because they originated from a common ancestor.
When orthology is unambiguous, proteins in the different species
generally retain the same function, essentially when the function is
critical to survival [34]. One reason for the maintenance of a motif
through evolution is that it provides a necessary function, such as
protein-protein interactions. The conservation of short peptide
motifs is associated with transient transactions and conservation of
larger domain motifs is associated with more stable protein-protein
interactions [34,47,48]. We identified these ER and SR proteins in
the human GO database which contain the di-arginine motif in a
variety of species using Basic Local Alignment Search Tool
(BLAST). The finding that the motif is conserved in 37 proteins in
horse and up to 69 proteins in chimpanzee (Figure 8) further
emphasizes the importance of the di-arginine motif.
It has been established that COP I binds directly to proteins
bearing the di-lysine motif. Several proteins containing the di-
lysine motif have been identified including ERGIC-53 and the
KDEL receptor. Recycling of both proteins was efficiently
inhibited when COP I function was blocked by microinjection
of COP-I antibodies [49]. The di-arginine motif has also been
shown to directly bind to the coatomer complex. The RSRR
signal in the GB1 subunit of GABAB, for example was shown to
specifically interact with COP I vesicles [39]. Further evidence of
the di-arginine motif binding to coatomer protein was provided
more recently by key mutations made to the a and b subunit of
COP I, which although led to the formation of the coatomer
complex had lost its ability to bind to the di-lysine motif [29].
In summary, we propose that PLN is retrieved from the golgi
apparatus through the COP I retrograde pathway, and that COP I
binds to the di-arginine motif in the cytoplasmic domain of PLN.
A greater understanding of PLN protein synthesis and proper
targeting in the cell may contribute novel approaches to deal with
human PLN mutations that result in improper PLN protein
synthesis, stability, or targeting. We also propose that the di-
arginine motif may act as a general ER/SR retrieval motif and
these finding warrants further investigation into the proper
targeting of di-arginine motif containing proteins.
Materials and Methods
Cell Culture and Antibodies
HEK-293 cells (commercially bought from ATCC) were
cultured in Dulbecco’s modified Eagle’s media H21 (Princess
Margaret Hospital, Toronto) supplemented with 10% fetal calf
serum and 1% non-essential amino acids. The culture and
transfection of HEK-293 cells has been described in pervious
publications [7,45]. Primary mouse fibroblasts were isolated from
differential platting of day 1 mouse hearts and cultured as
previously described [50]. Briefly, mouse hearts were digested with
50 U/ml collagenase typeII (Worthington Biochemicals, Lake-
wood, NJ) and 0.5 mg/ml trypsin (Invitrogen Canada Inc.,
Burlington, ON, Canada) in calcium- and bicarbonate-free Hanks’
buffer with HEPES. Dissociated cells were collected every 3 to
5 min. Fibroblast were collected by differential plating by utilising
the ability of the fibroblasts to attach to the tissue culture plates
faster than other cell types. Primary fibroblasts were then cultured
in Dulbecco’s modified Eagle’s media H21 (Princess Margaret
Hospital, Toronto) supplemented with 10% fetal calf serum and
1% non-essential amino acids. PLN antibody 1D11 was a kind gift
from Dr Robert G. Johnson. Other antibodies were obtained
commercially: FLAG antibody (M2)(Sigma), His antibody (Qia-
gen), COP I b subunit (Abcam), NCX (Santa Cruz), Na/K
ATPase (Hybridoma Bank), SERCA2a (Affinity Bioreagents),
ERGIC 53 (Sigma), Calnexin (Abcam), Calreticulin (Affinity
Bioreagents), PDI (Calbiochem), Estrogen Receptor beta (Abcam),
ARFGAP (Santa Cruz), ARF1 (Abcam), SOAT antibody (Abcam),
TGN46 (AbD Serotec) a kind gift from Dr Walter Kahr (U of
Toronto), Alexa mouse Fluor488 and rabbit Fluor633 (Invitrogen).
Expression plasmids and mutagenesis
Mutagenesis and deletion of cDNA encoding rabbit phospho-
lamban (PLN) containing a deletion of the arginine residue at
position 14 has been described in previous publications [4].
Additional mutants generated in this study were the N-flagged
PLN with R13E mutation, R13A, R13E/R14E double mutant.
The primers were as follows: R13E mutation sense
59ACTCGCTCTGCTATAGAAAGGGCCTCAACCATTGAA-
39 and antisense
59TTCAATGGTTGAGGCCCTTTCTATAGCAGAGCGAGT-
39:R 1 3 Am u t a t i o ns e n s e
59ACTCGCTCTGCTATAGCAAGGGCCTCAACCATTGAA-
39 and antisense
59-TTCAATGGTTGAGGCCCTTGCTATAGCAGAGCGA -
GT-39:
R13E/R14E mutation sense
Figure 8. Percentage conservation of the di-arginine, di-lysine
and XDEL motifs. (A) Graph representing the percentage of proteins
identified in our bioinformatic screen that contain one or more
transmembrane domains and retain the di-arginine or di-lysine motif or
retain the XDEL motif and are lumenal proteins in a variety of species
orthologues carried out using Basic Local Alignment Search Tool
(BLAST). The proteins searched were those found in the human IPI
protein sequence database that were annotated as ER (GO:0005783)
and SR (GO:0016529) and containing the di-arginine motif in the N-
terminal 25 residues or di-lysine motif in the C-terminal 25 residues and
XDEL at the C-terminus.
doi:10.1371/journal.pone.0011496.g008
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39, and antisense
59TTCAATGGTTGAGGCCTCTTCTATAGCAGAGCGAGT-
39:R D14 mutation sense
59ACTCGCTCTGCTATAAGAGCCTCAACCATTGAA-39
and antisense
59TTCAATGGTTGAGGCTCTTATAGCAGAGCGAGT-39.
Underlined nucleotide indicates residues changed from wild
type PLN in generating mutation (See Figure 1C)
Sigma 1R and SR b cDNA was purchased from Open
Biosystems in the pDONR223 Gateway Entry Vector and then
cloned into the Gateway pEF-Dest51 Vector (Invitrogen) which
Figure 9. Mistargeting of other di-arginine mutants. (A) Subcellular fractionation of wild type Sigma 1R and a di-arg to di-glu mutant Sigma 1R
construct. HEK cells were transiently transfected with tagged V5 Sigma 1R or tagged V5 di-arg to di-glu mutant Sigma 1R and cell lysates run on a
continuous 20–60% sucrose gradient. Sigma1R was detected using the anti-V5 antibody. (B) IP performed using cell lysates from wild type V5 tagged
Sigma 1R and V5 tagged di-arginine mutant Sigma 1R constructs transfected HEK cells. Proteins were immunoprecipitated using anti COP I antibody
and then immunoblotted with anti V5 antibody (right panel); with equivalent loading of lysates (left panel). Arrows indicate Sigma 1R and mutant
Sigma 1R. (C) Subcellular fractionation of wild type SR-b and di-arginine mutant SR-b construct. HEK cells were transiently transfected with V5 tagged
SR-b or V5 tagged di-arginine mutant SR-b and cell lysates run on a continuous 20–60% sucrose gradient. SRB was detected using anti-V5 antibody.
(D) IP performed using cell lysates from wild type V5 tagged SR-b and V5 tagged di-arginine mutant SR-b constructs transfected HEK cells and
immunoprecipitated using anti COP I antibody and then immunoblotted with anti V5 antibody (right panel); with equivalent loading of lysates (left
panel). Arrows indicate SR-b and mutant SR-b (E) Subcellular fractionation of wild type SOAT and di-arginine mutant SOAT construct. HEK cells were
transiently transfected with tagged SOAT and di-arginine mutant SOAT and cell lysates run on a continuous 20–60% sucrose gradient and detected
using anti-SOAT antibody (F) Tandem affinity purification of HEK cells transiently transfected with tagged SOAT and di-arginine mutant SOAT.
Purification was carried out using streptavidin beads first and calmodulin beads second. Samples were then probed with antibodies to detect COP I,
arrows indicate COP I (see methods for details).
doi:10.1371/journal.pone.0011496.g009
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1R were generated using the following primers for the double
mutant R7E/R8E: 59-TGG GCC GTG GGC GAG GAG TGG
GCG TGG GCC-39 sense and 59-GGC CCA CGC CCA CTC
CTC GCC CAC GGC CCA-39 antisense primers. The di-
arginine mutations were generated in SR b using the following
primers for the double mutant R7E/R8E: 59-TCC GCG GAC
TCG GAA GAG GTG GCA GAT GGC-39 sense and 59-GCC
ATC TGC CAC CTC TTC CGA GTC CGC GGA-39 antisense
primers. SOAT-1 cDNA was purchased from Origene Technol-
ogies (Rockville, MD) in a pCMV6 plasmid vector and then
inserted into the Interplay Mammalian TAP vector pCTAP from
Stratagene. Site directed mutagenesis of the SOAT-1 was
preformed using the following primers for the double mutant
R10E/R12E: 59-AAG ATG TCT CTA GAA AAC GAG CTG
TCA AAG TCC-39 sense 39GGA CTT TGA CAG CTC GTT
TTC TAG AGA CAT CTT 59 anti-sense primers. Underlined
bases indicate bases that were changed from wild type.
Sucrose Gradient Fractionation
HEK-293 cells transfected with PLN or the PLN di-arginine
mutants (PLN RD14, PLN R13E, PLN R13E/R14E) were
harvested 48 hours after transfection. Cells were resuspended in
a low ionic strength lysis buffer (10 mM Tris-HCl pH 7.5 and
0.5 mM MgCl2) and homogenised with 40 strokes in a dounce
homogeniser at 4uC. Buffer A (250 mM sucrose, 50 mM Tris-HCl
(pH 7.4), 1 mM PMSF, 20 mg/ml aprotinin) was added to further
help solubilisation and a further 20 strokes applied in the dounce
homogeniser. The sample was then centrifuged for 20 min at
14,000 g, and the supernatant was collected and layered on top of
a 20–60% linear sucrose gradient made up in 10 mM Tris-HCl
(pH 7.6), 10 mM EDTA and protease inhibitors (Roche). Samples
were centrifuged at 100,000 g for 20 hrs in a SW40Ti swinging
bucket rotor. Fractions (750 ml) were collected from the bottom of
each gradient and total protein concentration calculated by using
Bradford Reagent (Sigma).
Immunofluorescence
HEK-293 and fibroblast cells were grown on glass chamber
culture slides (BD-Falcon) and transfected using lipofectamine
(Invitrogen) following the manufacturers instructions. After
48 hours the cells were washed in phosphate buffered saline
(PBS) and fixed in 2% paraformaldehyde in PBS (pH 7.0). Non-
specific interactions were suppressed with 5% fetal bovine serum
(FBS) in permeabilization buffer (0.2% tween-20, 0.5% Triton X-
100 in PBS pH 7.0) for 30 minutes and then samples were
incubated with primary antibodies anti-PLN 1D11 and anti-COP
I in permeabilization buffer. Cells were then washed 3 times with
PBS and incubated with either Alexa Fluor 488 for PLN or Alexa
Fluor 633 for COP I. Images were collected by using a Leica DM
IRBE inverted microscope equipped with a Leica TCS SP laser
scanning confocal system. Spectra for Alexa Fluor 488 were
collected by excitation at l488 and emission collected between
l490–l510 and spectra for Alexa Fluor 633 were collected by
excitation at l633 and emission between l640–l670.
Immunoblot and immunoprecipitation
Immunoblot analyses were performed using standard SDS-
PAGE chemiluminescent procedures [9]. Immunoprecipitations
were carried out using Protein G-Sepharose beads (Pierce) [9].
Briefly, a post-nuclear fraction was obtained from cells transfected
with either PLN-WT, PLN RD14, PLN R13E/R14E, Sigma 1R-
WT, SRb-WT, SOAT-WT, Sigma 1R R7E/R8E, SRb R7E/
R8E, and SOAT R10E/R12E. Cells were collected in PBS
containing 5 mM EDTA and the pellet was washed once in PBS.
The cells were then lysed with 30 strokes in a tight- fitting glass
dounce homogeniser in lysis buffer (250 mM sucrose, 50 mM
Tris-HCl pH 7.6, 1 mM MgCl, 1 mM DTT, 1 mM PMSF). The
lysate was then cleared by centrifugation for 15 min at 2600 rpm
at 4uC. To allow antibody-protein complex formation, the cleared
lysate was incubated at 4uC under continuous rotation with
antibody in binding buffer (140 mM NaCl, 8 mM NaPO4, 2 mM
KPO4, 14 mM KCl pH 7.4) and 0.1% Triton-X100, 0.01% BSA
for 2 hours. Protein G-Sepharose beads were blocked in 0.1%
BSA in binding buffer for 2 hours. The beads were then pelleted
and added to protein sample and allowed to rotate overnight at
4uC. Samples were washed 5 times and then eluted in 0.1 M
glycine pH 2.3. Immunoprecipitation of endogenous PLN from
mouse cardiac muscle was carried out using the Seize-X Protein A
Immunoprecipitation Kit (Pierce) following the manufacturers
conditions. Antibody-protein G complexes were formed at 4uC for
4 hours, washed extensively, then incubated with post nuclear
extract overnight.
In-vitro binding assay
The cDNAs of COP (Open Biosystems), PLN and PLN RD14
were cloned into the His-tagged bacterial vector pET28-MHL
Vector (GenBank accession EF456735). The His-tagged proteins
were expressed in 1 liter of 2YT overnight at 37uC under
continuous shaking and protein production was induced by the
addition of IPTG. Bacterial pellets were centrifuged at 6000 g and
resuspended in binding buffer (50 mM Tris-HCl, pH 8.0,
200 mM NaCl, 1 mM b-mercaptoethanol and 2 mM imidazole,
pH 8.0) and incubated with cobalt beads overnight at 4uC under
continuous shaking. The beads were then washed 3 times for 20
minutes each with wash buffer (50 mM Tris-HCl, pH 8.0,
200 mM NaCl, 1 mM b-mercaptoethanol and 10 mM imidazole,
pH 8.0). Proteins were then eluted in elution buffer (50 mM Tris-
HCl, pH 8.0, 200 mM NaCl, 1 mM b-mercaptoethanol and
500 mM Imidazole, pH 8.0). Purified COP I and PLN or PLN
RD14 were incubated together and immunoprecipitation was
carried out as described above.
Tandem Affinity Purification
Due to cloning difficulties, SOAT cDNA (OriGene) was cloned
into the Interplay Mammalian TAP vector, pCTAP (Stratagene)
which contains a dual streptavidin binding peptide tag and a
calmodulin binding peptide tag. Purification was carried out as
recommended by the manufacturer in the Interplay TAP
purification kit (Stratagene). In short, the protein extract was
added to the washed steptavidin resin and rotated for 2 hours at
4uC to allow the tagged proteins to bind streptavidin via the
streptavidin binding protein (SBP) tag and washed three times in
wash buffer (Stratagene). For further purification, bound proteins
were bound to calmodulin beads for 2 hours at 4uC via their
calmodulin binding protein (CBP) tag. Beads were then washed
and eluted in elution buffer (Stratagene) and probed for SOAT
and COP, using the antibodies defined above.
Bioinformatics
ER retention motifs KK and RR within the first 25 residues and
ER retrieval motif XDEL in the C-termini of proteins were
retrieved from the human IPI protein sequence database from
proteins with GO identifications as ER (GO:0005783) and SR
(GO:0016529). Protein orthologues were then compared over
multiple species using BLAST (http://blast.ncbi.nlm.nih.gov/
Blast.cgi). Data analysis and annotation of cellular components
RR Motif and PLN Targeting
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Denmark) as described previously [51].
Supporting Information
Table S1 The list of proteins that contain the motif RR within
the proteins first 25 residues, KK within the proteins last 25
residues and proteins with the sequence XDEL at the C-terminus,
extracted from the human IPI protein sequence database from all
the human ER (GO: 0005783) and human SR (GO: 0016529)
proteins, which represents all proteins that have a known and
annotated ER and SR localization.
Found at: doi:10.1371/journal.pone.0011496.s001 (0.13 MB
XLS)
Table S2 A table of percentage conservation of the di-arginine,
di-lysine and XDEL motifs. Table showing the percentage of
proteins identified in our bioinformatic screen that contain one or
more transmembrane domains and retain the di-arginine or di-
lysine motif or retain the XDEL motif and are lumenal proteins in
a variety of species orthologues carried out using Basic Local
Alignment Search Tool (BLAST). Numbers in brackets represent
actual numbers.
Found at: doi:10.1371/journal.pone.0011496.s002 (0.02 MB
XLS)
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